Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancer

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 991-997

  Lüftner, Diana ^a,c   Mazurek, S ^a   Henschke, P ^b   Mesterharm, J ^a   Schildhauer, S ^a   Geppert, R ^a   Wernecke, K D ^c   Possinger, K ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Breast cancer; HER 2 neu; Pyruvate kinase; TuM2 PK; Tyrosine phosphorylation

Indexed keywords

BIOCHEMICAL MARKER; CA 27-29 ANTIGEN; ISOENZYME; ONCOPROTEIN; PROTEIN TYROSINE KINASE; PYRUVATE KINASE; TUMOR TYPE M2 PYRUVATE KINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; BREAST CARCINOMA; CELL TYPE; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE ACTIVITY; GENE FUNCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE NEU; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; REPRODUCIBILITY; TUMOR CELL;

ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BREAST NEOPLASMS; FEMALE; HUMANS; ISOENZYMES; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; PYRUVATE KINASE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037861913     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Bargmann CI, Hung MC and Weinberg RA: The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319(6050): 226-30, 1986.
2. Padhy LC, Shih C, Cowing D, Finkelstein R and Weinberg RA: Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 28(4): 865-71, 1982.
3. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244(4905): 707-12, 1989.
4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785): 177-82, 1987.
5. Andersen TI, Paus E, Nesland JM, McKenzie SJ and Borresen AL: Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour. Acta Oncol 34(4): 499-504, 1995.
6. Krainer M, Brodowicz T, Zeillinger R, Wiltschke C, Scholten C, Seifert M et al.: Tissue expression and serum levels of HER-2/neu in patients with breast cancer. Oncology 54(6): 475-81, 1997.
7. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H and Friis R: Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Reviews Oncogenesis 3: 91-115, 1993.
8. Cook GB, Neaman IE, Goldblatt JL, Cambetas DR, Hussain M, Luftner D et al.: Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer. Anticancer Res 21(2B): 1465-70, 2001.
9. Lüftner D, Mesterharm J, Akrivakis C, Geppert R, Petrides PE, Wernecke KD et al.: Tumor type M2 pyruvate kinase expression in advanced breast cancer. Anticancer Res 20: 5077-82, 2000.
10. Bhargava R, Naeem R, Marconi S; Luszcz J, Garb J, Gasparini R et al.: Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression. Hum Pathol 32(12): 1344-50, 2001.
11. Szollosi J, Balazs M, Feuerstein BG, Benz CC and Waldman FM: ERBB-2 (HER2/neu) gene copy number, p185HER-2 over-expression, and intratumor heterogeneity in human breast cancer. Cancer Res 55(22): 5400-7, 1995.
12. Rhodes A, Jasani B, Couturier J, McKinley MJ, Morgan JM, Dodson AR et al.: A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. Am J Clin Pathol 117(1): 81-9, 2002.
13. Muthuswamy SK and Muller WJ: Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo. Oncogene 11(9): 1801-10, 1995.
14. Mazurek S, Michel A and Eigenbrodt E: Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates. J Biol Chem 272: 4941-51, 1997.
15. Mazurek S, Weisse G, Wust G, Schafer-Schwebel A, Eigenbrodt E and Friis RR: Energy metabolism in the involuting mammary gland. In Vivo 13(6): 467-77, 1999.
16. Mazurek S, Grimm H, Wilker S, Leib S and Eigenbrodt E: Metabolic characteristics of different malignant cancer cell lines. Anticancer Res 18(5A): 3275-82, 1998.
17. Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA and Staal GE: Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 52(17): 4773-8, 1992.
18. Reiss N, Kanety H and Schlessinger J: Five enzymes of the glycolytic pathway serve as substrates for purified epidermal-growth-factor-receptor kinase. Biochem J 239(3): 691-7, 1986.
19. Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V and Israel MA: Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 261(29): 13754-9, 1986.
20. Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JG, Hennipman A et al.: c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 180(4): 383-8, 1996.
21. Hagemann C and Rapp UR: Isotype-specific functions of Raf kinases. Exp Cell Res 253(1): 34-46, 1999.
22. Presek P, Reinacher M and Eigenbrodt E: Pyruvate kinase type M2 is phosphorylated at tyrosine residues in cells transformed by Rous sarcoma virus. FEBS Lett 242(1): 194-8, 1988.
23. Weernink PA, Rijksen G, Mascini EM and Staal GE: Phosphorylation of pyruvate kinase type K is restricted to the dimeric form. Biochim Biophys Acta 1121(1-2): 61-8, 1992.